BL-M08D1 / Biokin Pharma - LARVOL DELTA

A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors (ChiCTR) - P1 | N=22 | Recruiting | Sponsor: Fudan University Shanghai Cancer Center; Fudan University Shanghai Cancer Center

New P1 trial • Solid Tumor

A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors (clinicaltrials.gov) - P1 | N=22 | Recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Oncology • Solid Tumor

A Study of BL-M08D1 in Patients With Relapsed or Refractory Lymphoid Malignancies (clinicaltrials.gov) - P1 | N=22 | Recruiting | Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting | Trial completion date: Jun 2027 ➔ Dec 2027 | Trial primary completion date: Dec 2026 ➔ Jun 2027

Enrollment open • Trial completion date • Trial primary completion date • Hematological Malignancies • Oncology